1. Home
  2. NX vs VALN Comparison

NX vs VALN Comparison

Compare NX & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

N/A

Current Price

$17.11

Market Cap

797.0M

Sector

Industrials

ML Signal

N/A

Logo Valneva SE

VALN

Valneva SE

N/A

Current Price

$10.50

Market Cap

875.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NX
VALN
Founded
1927
2012
Country
United States
France
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
797.0M
875.7M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
NX
VALN
Price
$17.11
$10.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$28.00
$15.75
AVG Volume (30 Days)
493.5K
17.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,837,641,000.00
N/A
Revenue This Year
$3.18
$2.58
Revenue Next Year
$2.27
$4.43
P/E Ratio
N/A
N/A
Revenue Growth
43.81
N/A
52 Week Low
$11.04
$5.43
52 Week High
$22.90
$12.25

Technical Indicators

Market Signals
Indicator
NX
VALN
Relative Strength Index (RSI) 27.59 50.40
Support Level $16.09 $8.37
Resistance Level $19.88 $12.22
Average True Range (ATR) 0.89 0.40
MACD -0.66 -0.09
Stochastic Oscillator 7.41 22.94

Price Performance

Historical Comparison
NX
VALN

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: